ESR1 and neoplasm: This study found that ER+ tumours were associated with a significantly higher 5-year OS (5-year OS = 85.0%; 95%CI: 83.2–86.7%) compared to ER- tumours (5-year OS = 75.7%; 95%CI: 72.8–78.4%; p < 0.001) [21].